[Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
Berent
H
H
Kancelarczyk
W L
WL
Zebrowski
M
M
Uchman
B
B
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy*; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage*; D013805:Theobromine / Q000031:analogs & derivatives*; D013997:Time Factors
D005343:Fibrinolytic Agents; D005340:Fibrinogen; D013805:Theobromine; D010431:Pentoxifylline
Wpływ długotrwałego leczenia pentoksyfilina na wybrane parametry układu fibrynolitycznego u chorych na miazdzyce zarostowa tetnic kończyn dolnych.